Exploring the "Other" subfamily of HECT E3-ligases for therapeutic intervention

被引:27
作者
Singh, Sunil [1 ]
Ng, Joel [1 ]
Sivaraman, J. [1 ]
机构
[1] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore
关键词
Other" subfamily HECT; Ubiquitination; Protein Degradation; Cancer; modification; E3 ubiquitin ligase; E3 UBIQUITIN LIGASE; GOLGI MEMBRANE DYNAMICS; INTERACTING PROTEIN 12; ANGELMAN-SYNDROME; TUMOR-SUPPRESSOR; PROTEASOMAL DEGRADATION; INTELLECTUAL DISABILITY; STRUCTURAL BASIS; HEPATOCELLULAR-CARCINOMA; POLYUBIQUITIN CHAINS;
D O I
10.1016/j.pharmthera.2021.107809
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The HECT E3 ligase family regulates key cellular signaling pathways, with its 28 members divided into three sub-families: NEDD4 subfamily (9 members), HERC subfamily (6 members) and "Other" subfamily (13 members). Here, we focus on the less-explored "Other" subfamily and discuss the recent findings pertaining to their biolog-ical roles. The N-terminal regions preceding the conserved HECT domains are significantly diverse in length and sequence composition, and are mostly unstructured, except for short regions that incorporate known substrate-binding domains. In some of the better-characterized "Other" members (e.g., HUWE1, AREL1 and UBE3C), structure analysis shows that the extended region (similar to aa 50) adjacent to the HECT domain affects the sta-bility and activity of the protein. The enzymatic activity is also influenced by interactions with different adaptor proteins and inter/intramolecular interactions. Primarily, the "Other" subfamily members assemble atypical ubiquitin linkages, with some cooperating with E3 ligases from the other subfamilies to form branched ubiquitin chains on substrates. Viruses and pathogenic bacteria target and hijack the activities of "Other" subfamily mem-bers to evade host immune responses and cause diseases. As such, these HECT E3 ligases have emerged as poten-tial candidates for therapeutic drug development. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页数:22
相关论文
共 48 条
  • [21] The role of NEDD4 related HECT-type E3 ubiquitin ligases in defective autophagy in cancer cells: molecular mechanisms and therapeutic perspectives
    Zhang, Rui
    Shi, Shaoqing
    MOLECULAR MEDICINE, 2023, 29 (01)
  • [22] Molecular Evolution, Neurodevelopmental Roles and Clinical Significance of HECT-Type UBE3 E3 Ubiquitin Ligases
    Ambrozkiewicz, Mateusz C.
    Cuthill, Katherine J.
    Harnett, Dermot
    Kawabe, Hiroshi
    Tarabykin, Victor
    CELLS, 2020, 9 (11)
  • [23] Targeting HECT-type E3 ligases - insights from catalysis, regulation and inhibitors
    Fajner, Valentina
    Maspero, Elena
    Polo, Simona
    FEBS LETTERS, 2017, 591 (17): : 2636 - 2647
  • [24] A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation
    A Depaux
    F Regnier-Ricard
    A Germani
    N Varin-Blank
    Oncogene, 2007, 26 : 6665 - 6676
  • [25] A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation
    Depaux, A.
    Regnier-Ricard, F.
    Germani, A.
    Varin-Blank, N.
    ONCOGENE, 2007, 26 (46) : 6665 - 6676
  • [26] Molecular targeting of E3 ligases - a therapeutic approach for cancer
    Lakshmanan, Manikandan
    Bughani, Usha
    Duraisamy, Senthil
    Diwan, Manish
    Dastidar, Sunanda
    Ray, Abhijit
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (07) : 855 - 870
  • [27] RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer
    Uchida, Chiharu
    Kitagawa, Masatoshi
    CURRENT CANCER DRUG TARGETS, 2016, 16 (02) : 157 - 174
  • [28] The role of NEDD4 related HECT-type E3 ubiquitin ligases in defective autophagy in cancer cells: molecular mechanisms and therapeutic perspectives
    Rui Zhang
    Shaoqing Shi
    Molecular Medicine, 29
  • [29] The emerging insight into E3 ligases as the potential therapeutic target for diabetic kidney disease
    Akhouri, Vivek
    Majumder, Syamantak
    Gaikwad, Anil Bhanudas
    LIFE SCIENCES, 2023, 321
  • [30] Cullin 5-RING E3 ubiquitin ligases, new therapeutic targets?
    Lamsoul, Isabelle
    Uttenweiler-Joseph, Sandrine
    Moog-Lutz, Christel
    Lutz, Pierre G.
    BIOCHIMIE, 2016, 122 : 339 - 347